TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Pharmalex Norway AS
Closing information (x1000 NOK)
Closing information | 2023/09 | 2022/12 | 2021/12 |
Turnover |
20,919
|
28,671
|
22,935 |
Financial expenses |
552
|
776
|
516 |
Earnings before taxes |
131
|
4,535
|
5,359 |
Total assets |
7,011
|
11,515
|
11,196 |
Current assets |
6,937
|
11,188
|
10,922 |
Current liabilities |
3,448
|
8,052
|
7,762 |
Equity capital |
3,563
|
3,463
|
3,434 |
- share capital |
100
![]() |
100
![]() |
100 |
Financial ratios
Fiscal year | 2023/09 | 2022/12 | 2021/12 |
Solvency |
50.8%
|
30.1%
|
30.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
0.6%
|
15.8%
|
23.4% |
Return on assets (ROA) |
9.7%
|
46.1%
|
52.5% |
Current ratio |
201.2%
|
138.9%
|
140.7% |
Return on equity (ROE) |
3.7%
|
131.0%
|
156.1% |
Change turnover |
-7,752
|
5,736
|
8,841 |
Change turnover % |
-27%
|
25%
|
63% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/09 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.